A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations
Clinical trial NCT02418000 · TERMINATED
Trial details
- NCT number
- NCT02418000
- Sponsor
- Spirita Oncology, LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-10
- Primary completion
- 2017-06-08
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.